Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
 EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

Volume 10, Number 10, October 2004

Virus-specific RNA and Antibody from Convalescent-phase SARS Patients Discharged from Hospital

Hoe Nam Leong,*† Kwai Peng Chan,† Ali S. Khan,‡§ Lynette Oon,† Su Yun Se-Thoe,† Xin Lai Bai,† Daniel Yeo,* Yee Sin Leo,* Brenda Ang,* Thomas G. Ksiazek,‡ and Ai Ee Ling†
*Tan Tock Seng Hospital, Singapore; †Singapore General Hospital, Singapore; ‡Centers for Diseases Control and Prevention, Atlanta, Georgia, USA; and §Global Outbreak Alert and Response Network, Geneva, Switzerland

 
 
Figure 3.
  Back to article
 

Figure 3. Cumulative results of first serologic testing of samples by week of illness. Serologic testing was performed by indirect enzyme immunoassay with severe acute respiratory syndrome–associated coronavirus lysate as the antigen.

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed September 13, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention